0001415889-24-013146.txt : 20240514
0001415889-24-013146.hdr.sgml : 20240514
20240514173513
ACCESSION NUMBER: 0001415889-24-013146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240510
FILED AS OF DATE: 20240514
DATE AS OF CHANGE: 20240514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Funck, Jr. Robert E.
CENTRAL INDEX KEY: 0001565892
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 24946014
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: D-378, AP6D-2
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
FORMER NAME:
FORMER CONFORMED NAME: Funck Robert E
DATE OF NAME CHANGE: 20130103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-05142024_090502.xml
X0508
4
2024-05-10
0000001800
ABBOTT LABORATORIES
ABT
0001565892
Funck, Jr. Robert E.
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
0
Common shares without par value
2024-05-10
4
M
0
10097
47
A
221438
D
Common shares without par value
2024-05-10
4
S
0
10097
104.5676
D
211341
D
Common shares without par value
20000
I
By Trust
Common shares without par value
20000
I
By Trust
Common shares without par value
18765
I
Profit Sharing Trust
Common shares without par value
500
I
By Daughter
Option (right to buy)
47
2024-05-10
4
M
0
10097
0
D
2016-02-20
2025-02-19
Common Shares
10097
45000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.55 to $104.62, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
Balance in the Abbott Laboratories Stock Retirement Trust as of May 10, 2024.
The reporting person disclaims beneficial ownership of all securities held by his daughter.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
2024-05-14